World Health organization (WHO) estimates indicate that death from stroke in low-income and middle-income countries (LMIC) accounted for 86% of stroke deaths worldwide, and the disability adjusted life years lost in these countries are almost seven times the number lost in high-income countries. Most of these LMIC are in Africa. Moreover, it is expected that as deaths from infectious diseases wane, the burden of stroke is likely to increase substantially over the next few decades in LMICs. Hypertension, the most potent modifiable risk factor for stroke, and once rare in Africa, is emerging as a serious endemic threat (about 37% of the general population in Nigeria, Africa's most populous country has hypertension). The occurrence of a stroke itself is the strongest predictor of a repeat event (secondary stroke), which carries an even higher risk of death than a first-time stroke. Given the aforementioned, there is an urgent need to craft and validate effective health care delivery programs that can mitigate the devastating consequences of stroke through enhanced control of high blood pressure in LMICs. To improve the delivery of secondary stroke preventive services in a LMIC (Nigeria), we will custom design and then test a chronic care model-based intervention called Tailored Hospital-based Risk Reduction to Impede Vascular Events after Stroke (THRIVES). To ensure that the THRIVES intervention is culturally-relevant and locally sustainable, we will first obtain information about barriers and facilitators of adherence to evidence-based secondary stroke prevention treatments in Nigeria based on input from stroke patients, caregivers, health providers, and hospital administrators. We will use this information to appropriately refine an intervention comprising a stroke patient report card, cell phone text messaging from providers, and in-clinic educational video sessions. Finally, we will to test the efficacy of the tailored THRIVES intervention among 334 stroke patients recently discharged from four medical care facilities in South Western Nigeria via a randomized-controlled trial. The primary study outcome measure will be systolic blood pressure reduction 12 months after enrollment. A second specific aim is to conduct a cost analysis of THRIVES from the perspective of the local governments in Nigeria, using costs of the intervention, cost equivalents of associated local resource utilization, and cost equivalents of the observed and projected vascular events. These data will be presented to key decision-makers in Nigeria, so they can weigh the benefits and implications of supporting THRIVES beyond the research award period. We anticipate that a successful program could also serve as a model of cost-effective quality stroke preventive care for implementation in other countries in Sub Saharan Africa.

Public Health Relevance

This research seeks to develop an effective and sustainable way of reducing the devastating and deadly impact of stroke in a low-income region of the world with poor medical infrastructure. It will do so by focusing on improving the treatment of the condition most closely tied to stroke, hypertension, using novel methods that incorporate the input of the local community. If successful, the strategy could serve as a ready model to be adapted by decision-makers in other under-resourced areas for lessening the burden of stroke (and other major public health challenges).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01NS079179-04
Application #
8660719
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Waddy, Salina P
Project Start
2012-05-01
Project End
2017-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Neurosciences
Type
Schools of Medicine
DUNS #
City
Charleston
State
SC
Country
United States
Zip Code
29403
Liu, Shimeng; Feng, Wuwei; Chhatbar, Pratik Y et al. (2017) Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis. J Neurol Sci 378:140-145
Sarfo, Fred Stephen; Ovbiagele, Bruce; Akassi, John et al. (2017) Baseline Prescription and One-Year Persistence of Secondary Prevention Drugs after an index Stroke in Central Ghana. eNeurologicalSci 6:68-73
Ojagbemi, Akin; Owolabi, Mayowa; Akinyemi, Joshua et al. (2017) Criterion Validity of the ""HRQOLISP-E"": A New Context-Specific Screening Tool for Poststroke Depression. Behav Neurol 2017:6515769
Lekoubou, Alain; Ovbiagele, Bruce (2017) PREVALANCE AND INFLUENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON STROKE OUTCOMES IN HOSPITALIZED STROKE PATIENTS. eNeurologicalSci 6:21-24
Owolabi, Mayowa; Sarfo, Fred; Howard, Virginia J et al. (2017) Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors. Stroke 48:1169-1175
Vedanthan, Rajesh; Bernabe-Ortiz, Antonio; Herasme, Omarys I et al. (2017) Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries. Cardiol Clin 35:99-115
Ojagbemi, Akin; Owolabi, Mayowa; Akinyemi, Joshua et al. (2017) Proposing a new stroke-specific screening tool for depression: Examination of construct validity and reliability. eNeurologicalSci 9:14-18
Sarfo, Fred Stephen; Nichols, Michelle; Qanungo, Suparna et al. (2017) Stroke-related stigma among West Africans: Patterns and predictors. J Neurol Sci 375:270-274
Park, J-H; Ovbiagele, B (2017) Post-stroke diastolic blood pressure and risk of recurrent vascular events. Eur J Neurol 24:1416-1423
Sarfo, Fred Stephen; Akassi, John; Badu, Elizabeth et al. (2016) Profile of neurological disorders in an adult neurology clinic in Kumasi, Ghana. eNeurologicalSci 3:69-74

Showing the most recent 10 out of 50 publications